11/14/2024
6:48 PM | Corbus Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
5:41 PM | Corbus Pharmaceuticals (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G | |
11/14/2024
2:09 PM | Corbus Pharmaceuticals (Subject)
Cormorant Asset Management, LP (Filed by)
| Form SC 13G/A | |
11/12/2024
1:34 PM | Corbus Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/12/2024
8:37 AM | Adage Capital Management, L.P. (Filed by)
Corbus Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/07/2024
3:58 PM | Corbus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
7:41 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
11/04/2024
10:28 AM | Corbus Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
6:51 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
5:06 PM | BlackRock, Inc. (Filed by)
Corbus Pharmaceuticals (Subject)
| Form SC 13G | |
10/15/2024
3:19 PM | Corbus Pharmaceuticals (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
09/24/2024
3:04 PM | Chen Bihua (Reporting)
Corbus Pharmaceuticals (Issuer)
Cormorant Asset Management, LP (Reporting)
Cormorant Global Healthcare Master Fund, LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
3:44 PM | CATLIN AVERY W (Reporting)
Corbus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2024
3:52 PM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2024
3:45 PM | Corbus Pharmaceuticals (Issuer)
Kung Winston (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/20/2024
3:48 PM | Corbus Pharmaceuticals (Issuer)
Kung Winston (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
7:15 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
3:42 PM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2024
4:58 PM | Cohen Yuval (Reporting)
Corbus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
4:59 PM | Corbus Pharmaceuticals (Issuer)
Moran Sean F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
8:21 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
4:25 PM | Cohen Yuval (Reporting)
Corbus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
4:25 PM | Corbus Pharmaceuticals (Subject)
Moran Sean F. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
3:30 PM | Corbus Pharmaceuticals (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:31 PM | CATLIN AVERY W (Reporting)
Corbus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:32 PM | Corbus Pharmaceuticals (Issuer)
Jenkins John Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
6:08 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2024
3:39 PM | Corbus Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/20/2024
3:30 PM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
7:00 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
7:30 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
8:17 AM | Corbus Pharmaceuticals (Issuer)
Moran Sean F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:58 PM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
3:59 PM | Corbus Pharmaceuticals (Filer)
| Form DEFA14A | |
03/22/2024
4:05 PM | Corbus Pharmaceuticals (Filer)
| Form PRE 14A | |
03/20/2024
11:15 PM | Corbus Pharmaceuticals (Filer)
| Form EFFECT | |
03/20/2024
4:07 PM | Corbus Pharmaceuticals (Filer)
| Form 424B3 | |
03/20/2024
4:10 PM | Corbus Pharmaceuticals (Filer)
| Form 10-K/A | |
03/20/2024
4:13 PM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
3:52 PM | Corbus Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/12/2024
4:19 PM | Corbus Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad) All of our key indicators are flashing the same signal: an altcoin season is fast approaching.
And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin |
03/12/2024
7:15 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
4:34 PM | Chen Bihua (Reporting)
Corbus Pharmaceuticals (Issuer)
Cormorant Asset Management, LP (Reporting)
Cormorant Global Healthcare Master Fund, LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:13 PM | Corbus Pharmaceuticals (Issuer)
Smethurst Dominic (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:07 PM | Corbus Pharmaceuticals (Issuer)
Smethurst Dominic (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/14/2024
3:45 PM | Corbus Pharmaceuticals (Subject)
K2 HealthVentures Equity Trust LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
2:19 PM | Cohen Yuval (Reporting)
Corbus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
2:26 PM | Corbus Pharmaceuticals (Issuer)
Moran Sean F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
3:47 PM | Corbus Pharmaceuticals (Subject)
Cormorant Global Healthcare Master Fund, LP (Filed by)
| Form SC 13G | |
02/05/2024
7:12 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/01/2024
7:55 PM | Corbus Pharmaceuticals (Filer)
| Form 8-K/A | |
02/01/2024
4:27 PM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/01/2024
4:09 PM | Corbus Pharmaceuticals (Filer)
| Form 424B5 | |
01/31/2024
8:16 AM | Corbus Pharmaceuticals (Filer)
| Form S-3MEF | |
01/30/2024
7:40 PM | Corbus Pharmaceuticals (Filer)
| Form 424B5 | |
01/30/2024
7:41 PM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/30/2024
5:07 PM | Corbus Pharmaceuticals (Issuer)
HOLMER ALAN F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
3:56 PM | Cohen Yuval (Reporting)
Corbus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
3:18 PM | Chen Bihua (Reporting)
Corbus Pharmaceuticals (Issuer)
Cormorant Asset Management, LP (Reporting)
Cormorant Global Healthcare Master Fund, LP (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/30/2024
3:23 PM | Chen Bihua (Reporting)
Corbus Pharmaceuticals (Issuer)
Cormorant Asset Management, LP (Reporting)
Cormorant Global Healthcare Master Fund, LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
3:40 PM | Corbus Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G | |
01/29/2024
6:30 AM | Corbus Pharmaceuticals (Filer)
| Form 424B3 | |
01/29/2024
6:31 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
7:45 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free CRBP Stock Alerts